What is the treatment for anaphylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Anaphylaxis

Intramuscular epinephrine is the first-line treatment for anaphylaxis and should be administered immediately upon recognition of symptoms. 1, 2

Immediate Management

  1. Epinephrine Administration:

    • Dose: 0.01 mg/kg of 1:1000 concentration (1 mg/mL) to a maximum of:
      • Adults: 0.5 mg (0.5 mL)
      • Children: 0.3 mg (0.3 mL) 2
    • Route: Intramuscular injection into the anterolateral thigh 1, 2
    • Timing: Administer immediately; delay increases risk of mortality 1
    • Repeat dosing: If symptoms persist, repeat dose after 5-15 minutes 2
  2. Emergency Response:

    • Activate emergency response system/call 911 1
    • Position patient appropriately (supine with legs elevated if hypotensive) 2
    • Monitor vital signs continuously 2
  3. Airway Management:

    • Assess airway, breathing, and circulation
    • Administer supplemental oxygen if needed 2

Secondary Interventions (after epinephrine)

  • Fluid Resuscitation: Rapid IV fluid bolus with crystalloids (1-2 L in adults) for hypotension 2
  • H1 Antihistamines: (e.g., diphenhydramine 25-50 mg IV/IM) for cutaneous symptoms 2
  • H2 Antihistamines: (e.g., ranitidine 1 mg/kg IV) may be used as adjunct therapy 2
  • Corticosteroids: (e.g., methylprednisolone 1-2 mg/kg IV) may help prevent protracted or biphasic reactions 2
  • Bronchodilators: Albuterol 2.5-5 mg via nebulizer for persistent bronchospasm 2

Management of Refractory Anaphylaxis

  • For hypotension unresponsive to initial epinephrine and fluids:
    • Consider epinephrine infusion (5-15 μg/min) 2
    • Consider IV epinephrine (1:10,000 concentration) for profound shock 1, 2
    • Glucagon 1-5 mg IV may be considered, especially in patients on beta-blockers 2

Observation Period

  • All patients should be observed for at least 4-6 hours after symptom resolution 2
  • Extended observation (8-24 hours) for:
    • Severe reactions
    • Patients requiring multiple epinephrine doses
    • History of biphasic reactions
    • Cardiovascular comorbidities 2

Follow-up Care

  • Prescribe epinephrine autoinjectors (2) and provide training on proper use 2
  • Develop an anaphylaxis emergency action plan 2
  • Refer to an allergist for identification of triggers and long-term management 2
  • Consider medical identification jewelry or wallet card 2

Important Considerations

  • No absolute contraindications exist for using epinephrine to treat anaphylaxis, even in elderly patients or those with cardiac disease 1, 2
  • Biphasic reactions can occur up to 72 hours later, with 17% of patients experiencing delayed deterioration 1, 2
  • Epinephrine autoinjectors should be stored properly and replaced before expiration 2
  • Common pitfalls include:
    • Delaying epinephrine administration while using antihistamines
    • Improper dosing or route (subcutaneous instead of intramuscular)
    • Failure to repeat dose when symptoms persist
    • Inadequate observation time after apparent resolution

Remember that anaphylaxis is a life-threatening emergency, and prompt administration of epinephrine is the most critical intervention that can save lives.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anaphylaxis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.